Literature DB >> 29764935

The disorderly conduct of Hsc70 and its interaction with the Alzheimer's-related Tau protein.

Isabelle R Taylor1, Atta Ahmad2, Taia Wu1, Bryce A Nordhues3, Anup Bhullar2, Jason E Gestwicki4, Erik R P Zuiderweg5.   

Abstract

Hsp70 chaperones bind to various protein substrates for folding, trafficking, and degradation. Considerable structural information is available about how prokaryotic Hsp70 (DnaK) binds substrates, but less is known about mammalian Hsp70s, of which there are 13 isoforms encoded in the human genome. Here, we report the interaction between the human Hsp70 isoform heat shock cognate 71-kDa protein (Hsc70 or HSPA8) and peptides derived from the microtubule-associated protein Tau, which is linked to Alzheimer's disease. For structural studies, we used an Hsc70 construct (called BETA) comprising the substrate-binding domain but lacking the lid. Importantly, we found that truncating the lid does not significantly impair Hsc70's chaperone activity or allostery in vitro Using NMR, we show that BETA is partially dynamically disordered in the absence of substrate and that binding of the Tau sequence GKVQIINKKG (with a KD = 500 nm) causes dramatic rigidification of BETA. NOE distance measurements revealed that Tau binds to the canonical substrate-binding cleft, similar to the binding observed with DnaK. To further develop BETA as a tool for studying Hsc70 interactions, we also measured BETA binding in NMR and fluorescent competition assays to peptides derived from huntingtin, insulin, a second Tau-recognition sequence, and a KFERQ-like sequence linked to chaperone-mediated autophagy. We found that the insulin C-peptide binds BETA with high affinity (KD < 100 nm), whereas the others do not (KD > 100 μm). Together, our findings reveal several similarities and differences in how prokaryotic and mammalian Hsp70 isoforms interact with different substrate peptides.
© 2018 Taylor et al.

Entities:  

Keywords:  chaperone; microtubule-associated protein (MAP); nuclear magnetic resonance (NMR); protein complex; protein conformation

Mesh:

Substances:

Year:  2018        PMID: 29764935      PMCID: PMC6036187          DOI: 10.1074/jbc.RA118.002234

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Mutations in the substrate binding domain of the Escherichia coli 70 kDa molecular chaperone, DnaK, which alter substrate affinity or interdomain coupling.

Authors:  D L Montgomery; R I Morimoto; L M Gierasch
Journal:  J Mol Biol       Date:  1999-02-26       Impact factor: 5.469

2.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

3.  Conserved, disordered C terminus of DnaK enhances cellular survival upon stress and DnaK in vitro chaperone activity.

Authors:  Robert G Smock; Mandy E Blackburn; Lila M Gierasch
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

4.  Structural and Biological Interaction of hsc-70 Protein with Phosphatidylserine in Endosomal Microautophagy.

Authors:  Kateryna Morozova; Cristina C Clement; Susmita Kaushik; Barbara Stiller; Esperanza Arias; Atta Ahmad; Jennifer N Rauch; Victor Chatterjee; Chiara Melis; Brian Scharf; Jason E Gestwicki; Ana-Maria Cuervo; Erik R P Zuiderweg; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-07-12       Impact factor: 5.157

5.  The amino acid sequence of the C-peptide of human proinsulin.

Authors:  A S Ko; D G Smyth; J Marktussen; F Sundby
Journal:  Eur J Biochem       Date:  1971-05-28

6.  Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.

Authors:  Aikaterini Rousaki; Yoshinari Miyata; Umesh K Jinwal; Chad A Dickey; Jason E Gestwicki; Erik R P Zuiderweg
Journal:  J Mol Biol       Date:  2011-06-25       Impact factor: 5.469

7.  Guidelines for the nomenclature of the human heat shock proteins.

Authors:  Harm H Kampinga; Jurre Hageman; Michel J Vos; Hiroshi Kubota; Robert M Tanguay; Elspeth A Bruford; Michael E Cheetham; Bin Chen; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2008-07-29       Impact factor: 3.667

8.  An atomistic view of Hsp70 allosteric crosstalk: from the nucleotide to the substrate binding domain and back.

Authors:  Federica Chiappori; Ivan Merelli; Luciano Milanesi; Giorgio Colombo; Giulia Morra
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

9.  Solution conformation of wild-type E. coli Hsp70 (DnaK) chaperone complexed with ADP and substrate.

Authors:  Eric B Bertelsen; Lyra Chang; Jason E Gestwicki; Erik R P Zuiderweg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-13       Impact factor: 11.205

Review 10.  Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias.

Authors:  J Q Trojanowski; M L Schmidt; R W Shin; G T Bramblett; D Rao; V M Lee
Journal:  Brain Pathol       Date:  1993-01       Impact factor: 6.508

View more
  15 in total

1.  Allosteric landscapes of eukaryotic cytoplasmic Hsp70s are shaped by evolutionary tuning of key interfaces.

Authors:  Wenli Meng; Eugenia M Clerico; Natalie McArthur; Lila M Gierasch
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-05       Impact factor: 11.205

Review 2.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

Review 3.  Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson's disease.

Authors:  Nina Aghazadeh; Elmira Aboutalebi Vand Beilankouhi; Farima Fakhri; Morad Kohandel Gargari; Parisa Bahari; Aliasghar Moghadami; Zhila Khodabandeh; Mohammad Valilo
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

4.  An allosteric inhibitor of bacterial Hsp70 chaperone potentiates antibiotics and mitigates resistance.

Authors:  Jordan Hosfelt; Aweon Richards; Meng Zheng; Carolina Adura; Brock Nelson; Amy Yang; Allison Fay; William Resager; Beatrix Ueberheide; J Fraser Glickman; Tania J Lupoli
Journal:  Cell Chem Biol       Date:  2021-11-23       Impact factor: 9.039

5.  Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor.

Authors:  Bahareh Eftekharzadeh; Varuna C Banduseela; Giulio Chiesa; Paula Martínez-Cristóbal; Jennifer N Rauch; Samir R Nath; Daniel M C Schwarz; Hao Shao; Marta Marin-Argany; Claudio Di Sanza; Elisa Giorgetti; Zhigang Yu; Roberta Pierattelli; Isabella C Felli; Isabelle Brun-Heath; Jesús García; Ángel R Nebreda; Jason E Gestwicki; Andrew P Lieberman; Xavier Salvatella
Journal:  Nat Commun       Date:  2019-08-08       Impact factor: 17.694

6.  The Evolution of Tau Phosphorylation and Interactions.

Authors:  Nataliya I Trushina; Lidia Bakota; Armen Y Mulkidjanian; Roland Brandt
Journal:  Front Aging Neurosci       Date:  2019-09-18       Impact factor: 5.750

Review 7.  Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046

8.  Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer.

Authors:  Yizeng Fan; Tao Hou; Yang Gao; Weichao Dan; Tianjie Liu; Bo Liu; Yule Chen; Hongjun Xie; Zhao Yang; Jiaqi Chen; Jin Zeng; Lei Li
Journal:  Autophagy       Date:  2021-05-26       Impact factor: 13.391

Review 9.  Hsp70 chaperone: a master player in protein homeostasis.

Authors:  María Rosario Fernández-Fernández; José María Valpuesta
Journal:  F1000Res       Date:  2018-09-19

10.  Selective Binding of HSC70 and its Co-Chaperones to Structural Hotspots on CFTR.

Authors:  Imad Baaklini; Conrado de Campos Gonçalves; Gergely L Lukacs; Jason C Young
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.